Identifying the Right Investigators and Patients for your Study – Mini Podcast Biosimilar Development Capabilities – Watch Now Vaccine Development Capabilities - Brochure Check out our latest Validated PK & ADA Methods List Read about Veeda's partnership with Ahammune Biosciences for first in human studies Check out our Assay List (Method Library)

Brochure / Flyer

01. Phase I Capabilities
02. Veeda Oncology Capabilities
03. Vaccine and Biosimilar Development Capabilities
04. Infectious Diseases Drug-development Solutions
05. Oncology - Large Molecule Capabilities
06. Phase 1 Trials Expertise | Veeda
07. Oncology- Small Molecules Development Capabilities
08. Veeda Group - Integrated Drug-development Services
09. Complex Generics and 505(b)(2) Whitepaper
10. Preclinical Drug Development Program
11. Aripiprazole LAI: An Overview of Veeda’s Approach to streamline Schizophrenia Drug Trials
12. Olaparib - An Overview of PARP Inhibitors and Clinical Trials
13. Veeda's Capabilities in Pazopanib Clinical Trials
14. Biostatistics and Clinical Trials Data Management
15. Determination of Free Doxorubicin and Liposomal Doxorubicin in K3EDTA Human Plasma
16. Trial Design for COVID Studies
01. Determination of Doxorubicin in Human Plasma
02. Approach for Quantitation of Iron in Human Serum Samples

Request for Proposal

Submit your details and we’ll be in touch shortly. You can also email us if you would prefer.